Pillar 01
Formulation Intelligence
Formulators spend years searching literature for ingredient interactions, stability data, and regulatory constraints. We compressed that search into seconds.
Visit theformulator.ai →NATURAL PRODUCT INTELLIGENCE
Closing the gap between what science knows and what industry can use.
The natural product universe contains over a million bioactive molecules with applications spanning cosmetic actives, pharmaceutical leads, and rare disease therapeutics. Most are unstudied. None are systematically accessible. We are changing that.
THE PROBLEM
Science knows more than industry can use.
Forty million scientific papers. Hundreds of molecular databases. Dozens of regulatory markets. The information exists — but it is fragmented, inaccessible, and unusable by the people who need to act on it.
Formulators spend years on literature searches that should take minutes. Discovery scientists miss leads because the data is too scattered to mine. Regulatory teams navigate eight markets manually. The gap is not a knowledge problem. It is an infrastructure problem.
2.07M
Natural product structures
1.3M+
Full-text scientific papers indexed
8
Regulatory markets — cosmetic and pharmaceutical
13
Tier 1 novel leads confirmed
OUR APPROACH
Four pillars. One mission.
Pillar 02
Natural Product Discovery
Over two million bioactive molecules exist across plant, marine, and microbial kingdoms. Most have never been tested against modern targets. We built the 7-layer AI pipeline to find the ones that matter — from literature ingestion to INCI novelty confirmation across 8 regulatory markets. Every candidate is assessed for dual application — cosmetic INCI novelty and pharmaceutical activity — simultaneously.
Explore the discovery platform →Pillar 03
In Silico Models for Nature
Existing QSAR and bioactivity models were trained on synthetic drug libraries built around Lipinski's rules. Natural products break those rules. We are building the first generation of predictive models trained exclusively on natural product chemical space — over 2 million structures, purpose-built for how nature actually does chemistry.
In developmentPillar 04
Rare Metabolic Disorders
Hundreds of millions live with metabolic disorders that receive a fraction of drug discovery investment. Rare and neglected conditions are systematically underserved. Natural products — particularly plant-derived phytochemicals and peptides — offer untapped therapeutic potential. We are building the discovery infrastructure to find them.
In developmentLet's work together.
We work with cosmetic ingredient companies, pharmaceutical partners, nutraceutical companies, CROs, and impact investors. If you are solving a problem in natural product formulation or discovery, we want to hear from you.
contact@aurentisscience.comAurentis Science Pvt. Ltd. — Mumbai, India